Novo Nordisk’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster fat-decline drugs, although the Danish business has far bigger ambitions.They converge with other societal alterations, such as globalisation of health treatment and raising problems of health disparities around the globe, which were exacerbated because of the p